Ticker Scorecard - BEAM Basics Company: Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.12B Activated in VL: True Average Daily Range Avg Daily Range: $1.65 | 3.47% Avg Daily Range (30 D): $0.79 | 2.99% Avg Daily Range (90 D): $0.80 | 3.11% Institutional Daily Volume Avg Daily Volume: .81M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): .87M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 2,730 Avg Inst. Trade: $3.17M Avg Inst. Trade (30 D): $3.03M Avg Inst. Trade (90 D): $2.91M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.84M Avg Closing Trade (30 D): $5.25M Avg Closing Trade (90 D): $4.46M Avg Closing Volume: 121.96K     News Jan 30, 2025 @ 12:00 PM Beam Therapeutics to Participate in Guggenheim SMI... Source: N/A Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Dec 8, 2024 @ 6:45 PM Beam Therapeutics Presents New Non-human Primate (... Source: N/A Dec 7, 2024 @ 4:30 PM Beam Therapeutics Announces New Data from BEACON P... Source: N/A Dec 6, 2024 @ 12:00 PM Beam Therapeutics Announces Appointment of Sravan ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.58 $-1.17 $-1.11 Diluted EPS $-1.58 $-1.17 $-1.11 Revenue $ 349.64M $ 14.27M $ 11.77M Gross Profit $ $ $ Net Income / Loss $ -143.59M $ -96.67M $ -91.05M Operating Income / Loss $ -182.67M $ -106.5M $ -104.9M Cost of Revenue $ $ $ Net Cash Flow $ 59.02M $ -62.17M $ 4.62M PE Ratio